TruBridge (TBRG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
4 Jun, 2026Executive summary
A special meeting is scheduled for July 7, 2026, for shareholders to vote on a proposed merger where TruBridge will be acquired by Inventurus Knowledge Solutions, Inc. (IKS) and become a wholly owned subsidiary of IKS.
Shareholders will receive $26.25 in cash per share, representing a premium over recent trading prices.
The board unanimously recommends approval of the merger, citing a robust sale process, premium valuation, and certainty of cash consideration.
The merger is subject to regulatory approvals, including antitrust clearance and approval by TopCo shareholders in India.
If the merger is not completed, TruBridge will remain independent, and termination fees may apply.
Voting matters and shareholder proposals
Shareholders will vote on two main proposals: (1) adoption of the Merger Agreement and (2) a non-binding advisory vote on compensation for named executive officers related to the merger.
Approval of the merger requires a majority of outstanding shares; the compensation proposal requires a majority of votes cast.
Support agreements with major shareholders (Pinetree, L6, Ocho) cover about 27.3% of voting power, committing them to vote in favor of the merger.
Appraisal rights are available for dissenting shareholders under Delaware law.
Board of directors and corporate governance
The board conducted a comprehensive strategic review, including outreach to 60 potential buyers and engagement with financial and legal advisors.
The board considered multiple offers and determined the IKS proposal offered the best value and certainty.
The board is composed of a majority of independent directors and followed a process to avoid conflicts of interest.
Latest events from TruBridge
- Shareholders to vote on cash merger at $26.25/share; board and major holders support the deal.TBRG
Proxy filing21 May 2026 - Q1 2026 saw $86.3M revenue, rising non-GAAP net income, and a pending IKS acquisition.TBRG
Q1 20268 May 2026 - TruBridge's acquisition by IKS Health targets improved healthcare access and operational stability.TBRG
Proxy filing23 Apr 2026 - IKS Health to acquire TruBridge for $557M, creating a leading healthcare solutions platform.TBRG
Proxy filing23 Apr 2026 - TruBridge will be acquired by IKS for $26.25 per share in cash, pending approvals.TBRG
Proxy filing23 Apr 2026 - Margin gains, strong recurring revenue, and GAAP profitability marked the year.TBRG
Q4 202531 Mar 2026 - RCM gains and margin expansion offset EHR declines as full-year guidance is reaffirmed.TBRG
Q2 20242 Feb 2026 - RCM growth, offshoring, and analytics drive TruBridge's margin and operational focus.TBRG
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Revenue and bookings rose, but net loss widened and internal control weaknesses persisted.TBRG
Q3 202415 Jan 2026